CSL Ltd.
ISIN AU000000CSL8
|WKN 890952
Overzicht
Koers
Handel met je broker
Beschrijving
CSL Ltd. est une société biopharmaceutique qui se consacre à la fabrication, à la commercialisation et à la distribution de produits biopharmaceutiques et connexes. Elle opère à travers les segments suivants : CSL Behring, CSL Seqirus et CSL Vifor. Le segment CSL Behring fournit des produits plasmatiques, des thérapies géniques et des recombinants. Le segment CSL Seqirus comprend principalement des produits liés à la grippe et fournit des services de pandémie aux gouvernements. Le segment CSL Vidor se concentre sur la distribution de produits dans les domaines thérapeutiques de la carence en fer et de la néphrologie. La société a été fondée le 2 novembre 1961 et son siège social se trouve à Melbourne, en Australie.
Santé Produits biopharmaceutiques Autres produits biopharmaceutiques Australie
Financiële kerngegevens
Kerncijfers
| Marktkapitalisatie, EUR | 65 387,16 M |
| WPA, EUR | - |
| KBV | 3,91 |
| K/W | 28,10 |
| Dividendrendement | 1,76% |
Winst- en verliesrekening (2024)
| Omzet, EUR | 13 595,08 M |
| Netto-inkomen, EUR | 2 445,08 M |
| Winstmarge | 17,99% |
In welke ETF zit CSL Ltd.?
Er zijn 212 ETF's die CSL Ltd. bevatten. Al deze ETF's staan in de tabel hieronder. De ETF met de grootste weging van CSL Ltd. is de UBS ETF (IE) MSCI Australia UCITS ETF (hedged to USD) A-acc.
Prestaties
Rendementsoverzicht
| YTD | -22,57% |
| 1 maand | -9,99% |
| 3 maanden | -24,32% |
| 6 maanden | -29,21% |
| 1 jaar | -24,20% |
| 3 jaar | -28,95% |
| 5 jaar | -31,61% |
| Since inception | +115,70% |
| 2024 | -5,02% |
| 2023 | -3,34% |
| 2022 | -2,88% |
| 2021 | +4,94% |
Maandelijks rendement in een heat map
Risico
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risico-overzicht
| Volatiliteit 1 jaar | 20,11% |
| Volatiliteit 3 jaar | 19,87% |
| Volatiliteit 5 jaar | 22,44% |
| Rendement/Risico 1 jaar | -1,20 |
| Rendement/Risico 3 jaar | -0,54 |
| Rendement/Risico 5 jaar | -0,33 |
| Maximaal waardedaling 1 jaar | -32,27% |
| Maximaal waardedaling 3 jaar | -36,91% |
| Maximaal waardedaling 5 jaar | -36,91% |
| Maximaal waardedaling sinds aanvang | -38,96% |
Voortschrijdende volatiliteit over 1 jaar
Nieuwste artikelen
— Gegevens verstrekt door Trackinsight, etfinfo, Xignite Inc., gettex, FactSet en justETF GmbH.
Standaard zijn ETF-rendementen inclusief dividenduitkeringen (indien van toepassing).
Standaard zijn ETF-rendementen inclusief dividenduitkeringen (indien van toepassing).
